Intelligent Bio Completes Study to Support FDA 510(k) Submission
Intelligent Bio Solutions completed a usability study for its Intelligent Fingerprinting Drug Screening System confirming effective use by non-specialist operators. This milestone …
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Intelligent Bio Solutions completed a usability study for its Intelligent Fingerprinting Drug Screening System confirming effective use by non-specialist operators. This milestone …
Summit Therapeutics announced the HARMONi-GU1 Phase II/III trial for ivonescimab in first-line bladder cancer. The study targets a major indication for ii antibodies in oncology.
NewAmsterdam Pharma reported strong Q2 results including a positive European regulatory opinion for obicetrapib, signaling significant progress for its late-stage CVD pipeline.
The Federal Reserve Board has approved the application by FS Bancorp, Inc.
The Federal Reserve Board has approved the application by Banco Santander, S.A. and Santander Holdings USA, Inc.
Catalyst Acquisition Corp. reported $201,915,212 in total assets as of July 29, 2026, with cash held in its Trust Account totaling $200 million. The company also filed an audit opi…
OrthoPediatrics filed a quarterly report identifying forward-looking statements regarding future profitability, capital needs, product commercialization, and operating factors. Mar…
The SPAC amended its certificate of incorporation to extend the deadline for completing a business combination to August 5, 2027 and to allow redemption rights for amendments to th…
CervoMed Inc. received an Innovation Passport for neflamapimod under the UK's ILAP program to accelerate its development for Lewy body dementia. Regulatory approval marks a signifi…
Elite Pharmaceuticals announced the U.S. commercial launch of its generic Requip XL tablets, a non-ergoline dopamine agonist used to treat Parkinson's disease. The product offers a…
Larimar Therapeutics submitted the first module of a rolling BLA for nomlabofusp in June and reported $156.3 million in cash as of June 30, 2026, extending their runway into Q3 202…
Accountant Ernst & Young consented to incorporation into several SEC filings, including several related to the company's compensation plans. The consent pertains to audits of a sub…
Intelligent Bio Solutions has completed an interference study to validate the accuracy of its drug screening system under real-world conditions, solidifying plans to submit the FDA…
KBRA affirmed all credit ratings for Bancorp and its subsidiary, citing industry leadership and strong financial metrics.
AEON Biopharma has resolved deficiencies in stockholders' equity by closing a public offering, removing the '.BC' listing indicator. The capital raise supports the rollout of its A…
Comfort Systems USA Inc. filed an 8-K. The document contains a presentation and Safe Harbor statements regarding future business expectations, revenue and operating results based o…
Innovate Corp filed a Supplemental Indenture to allow payment via PIK Notes or principal increases. The amendment received consents from holders of a majority of outstanding Notes.
Rocket Pharmaceuticals reported that its RP-A501 gene therapy was well-tolerated with no significant safety concerns observed in three treated patients, leading the company to enga…
Tonix Pharmaceuticals announced positive feedback for the design of an adaptive Phase 2 Lyme disease study of TNX-4800, with plans to begin the trial in early 2027. The long-acting…
Electro-Sensors has filed an amended and restated certificate of incorporation with the SEC, permanently changing its corporate governance structure. This action does not appear to…